Medical Director, Palliative Care, William Osler Health System - Brampton and Etobicoke, Toronto Regional Clinical Co- Lead, Physician for the Central West Palliative Care Network, Associate Clinical Professor, Department of Family Medicine, Faculty of Health Sciences , McMaster University, Site Lead, Residency program for Royal College Palliative Medicine Program, University of Toronto Affiliate Investigator, Bruyere Research Institute, Ottawa Associate professor, Department of Medicine, University of Toronto
Dr. Martin Chasen, born in Pretoria, South Africa completed his undergraduate training at the University of Pretoria in 1983, later obtaining a specialist degree in Internal Medicine and Medical Oncology and Master of Philosophy (Palliative Medicine) at the University of Cape Town, South Africa. He is a founding member of the palliative care working group European Society of Medical Oncology and faculty member of ESMO education. He is currently the Medical Director of Palliative Care, at William Osler Health System in Brampton. He was previously the Medical Director, Palliative Care, at The Ottawa Hospital Cancer Centre and the Palliative Rehabilitation Program at Élisabeth Bruyère Ottawa. He currently holds professorships at the Universities of Toronto, McMaster, Ottawa and McGill. He received the Elizabeth J Latimer Prize in Palliative Care from Mc Master University and Kay Blair Community Service Award, William Osler Health System. He has in excess of 100 peer reviewed publications, abstracts and book chapters. He is the principle investigator of Canadian Institutes of Health Research. MENAC (The Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia), trial. He is also one of the chief investigators for clinical trials using Rolapitant-a novel NKI inhibitor in the treatment of chemo therapy induced nausea and vomiting. He is on the Editorial Board, SA Journal of Oncology and Editor in Chief, Current Oncology. Dr. Chasen has lectured internationally and nationally – and appeared on media including as invited Speaker “Palliative Care”, House of Commons, Parliament of Canada, Dr Chasen was the Regional Palliative care physician lead for Palliative Care- Champlain LHIN and is presently the Medical co-lead for the Palliative Care Network in the Central West LHIN. Dr. Chasen is a teacher and mentor to his peers, including being a LEAP Facilitator. He was recently appointed to be an executive member of the CCTG Supportive Care Committee. When Dr. Chasen is not lecturing, teaching, mentoring or researching, he enjoys spending time with his beautiful wife, two daughters and two grandchildren. His enjoyment of arts and theatre are one of many of his passions.
Academic and Research Interests
- Medical Oncology; Palliative Medicine; Rehabilitation; Survivorship; anorexia/cachexia.
- Palliative Medicine
The focus of Dr. Chasen’s research is to understand the muscular fatigue and loss of strength in patients undergoing treatments for cancer, and to further investigate underlying mechanisms and clinical approaches to treating the symptoms of patients with anorexia/cachexia syndrome. Dr. Chasen has authored more than 105 peer-reviewed articles and book contributions and 220 abstracts. He currently has clinical trials underway in cancer cachexia.
Current Research Projects
- The Palliative Rehabilitation Programme: Enhancing Functioning, Appetite and Quality of Life in Cancer Patients. Principal Investigator: Dr Martin Chasen.
- Medical Cannabis in Cancer (MC2): Efficacy and Safety of Cannabis in Symptom Management.
- Canadian Cancer Rehabilitation (CanRehab) Team: Improving the systematic identification, management, and treatment of the adverse effects of cancer.
- CCS/ CIHR Survivorship Team Grant
- Psilocybin for psychological and existential distress in palliative care
- Use of an automated prospective clinical surveillance tool to drive screening for unmet palliative needs among patients in the final year of life
- A Prospective, Observational Study Evaluating the Incidence of Nausea and Vomiting in Patients with Cancer Receiving Carboplatin-Based Therapy
- The Effect of Ginger (Zingiber officinale) in Patients with the Cancer Anorexia/Cachexia Syndrome. Principal Investigator: Dr Martin Chasen
- Role of Ensure Enlive on appetite, calorie and protein intake, body composition and physical function in patients with advanced cancer receiving chemotherapy
- Modified Palliative Rehabilitation Program
Contact Information and Social Media
Phone: 905-494-2120 ext 57342
Research gate: https://www.researchgate.net/profile/Martin_Chasen